China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	40.69B -23.4%
Revenue (ttm)	32.88B +21.0%
Net Income	3.23B -1.4%
EPS	1.94 -0.9%
Shares Out	1.66B
PE Ratio	12.59
Forward PE	11.25
Dividend	1.04 (4.25%)
Ex-Dividend Date	May 29, 2026

Volume	17,121,705
Open	24.63
Previous Close	24.21
Day's Range	23.57 - 24.63
52-Week Range	23.73 - 33.45
Beta	0.12
Analysts	Buy
Price Target	36.84 (+50.68%)
Earnings Date	Aug 20, 2026

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 30,304
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2025, SHE:000999's revenue was 31.60 billion, an increase of 14.43% compared to the previous year's 27.62 billion. Earnings were 3.42 billion, an increase of 1.58%.